1. Home
  2. BHVN vs LZB Comparison

BHVN vs LZB Comparison

Compare BHVN & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$8.96

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$31.59

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
LZB
Founded
2013
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2022
1994

Fundamental Metrics

Financial Performance
Metric
BHVN
LZB
Price
$8.96
$31.59
Analyst Decision
Buy
Strong Buy
Analyst Count
14
2
Target Price
$28.85
$42.50
AVG Volume (30 Days)
1.9M
366.3K
Earning Date
03-02-2026
02-17-2026
Dividend Yield
N/A
2.97%
EPS Growth
26.08
N/A
EPS
N/A
1.65
Revenue
N/A
$2,349,433,000.00
Revenue This Year
N/A
$1.89
Revenue Next Year
N/A
$2.09
P/E Ratio
N/A
$19.74
Revenue Growth
N/A
N/A
52 Week Low
$7.48
$29.03
52 Week High
$31.18
$44.49

Technical Indicators

Market Signals
Indicator
BHVN
LZB
Relative Strength Index (RSI) 30.23 28.64
Support Level $8.40 $29.03
Resistance Level $15.66 $39.71
Average True Range (ATR) 0.65 0.84
MACD -0.14 -0.17
Stochastic Oscillator 4.26 3.26

Price Performance

Historical Comparison
BHVN
LZB

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

Share on Social Networks: